Early detection saves lives.
We’re developing next-generation molecular imaging technologies that find cancer and other diseases using bio-safe magnetic nanoparticles.
Treatments are more successful and survival rates improve with early detection.
By combining high-sensitivity imaging technologies with nanoparticle technology, we aim to make the detection of diseases like cancer better and safer for patients as well as provide new methods for therapeutic intervention.
Updated strategy to develop the MagSense® nanoparticle technology for use with clinical MRI systems.
Presented interim data from MagSense® HER2 Breast Cancer Phase I study at the San Antonio Breast Cancer Symposium showing imaging agent showed no safety findings of significance and reaches its target tissue (axillary lymph nodes) with the planned route of administration and shows unique and differentiable MR contrast pattern in nodes suspicious for tumor.
Presented prostate cancer research data at the World Molecular Imaging Congress with MagSense® imaging agent showing high specificity and selectivity
Sponsored Research Agreement executed with researchers at Massachusetts General Hospital focuses on MRI
MagSense® HER2 Breast Cancer Phase I study interim results indicate imaging agent is well-tolerated and is reaching patient’s lymph nodes
Joint Development Agreement with Global Cancer Technologies to develop nanocrystals for treatment of breast cancer
Collaboration with Patrys (ASX:PAB) for Brain Cancer imaging
First patient dosed in Phase I study
Receive CSIRO grant to support Prostate Cancer imaging research
MagSense® HER2 Breast Cancer Phase I study opens for enrolment
Research collaboration with Siemens
Received FDA designation as a ”Breakthrough Device”
Why you should use our PrecisionMRX® magnetic nanoparticles for your biomedical application
We have developed a proprietary method for making magnetic nanoparticles that precisely controls for key attributes, such as size, dispersity, and magnetic properties, important in biomedical application.
There are three biomedical applications of our magnetic nanoparticles.
Research & Imaging
We sell our PrecisionMRX® nanoparticles to institutions for research purposes.
Multiple coating types available.
Whitelabeled OEM Products
We supply nanoparticles that can be used in third-party branded products across hyperthermia, human and animal vaccines, and cancer screening and treatments.
MagSense® imaging agents can be developed for many types of solid tumors and can be used at multiple stages of diagnosis including primary diagnosis, staging, and prognosis of diseases.
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.